메뉴 건너뛰기




Volumn 32, Issue 6, 2011, Pages 389-401

Interpretability, validity, and the minimum important difference

Author keywords

Charles Taylor; Interpretation; Measurement; Quality of life

Indexed keywords

ARTICLE; CLINICAL TRIAL (TOPIC); ETHICS; HUMAN; OUTCOME ASSESSMENT; PATIENT SATISFACTION; QUALITY OF LIFE; REPRODUCIBILITY; STANDARD; TREATMENT OUTCOME;

EID: 84855323155     PISSN: 13867415     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11017-011-9186-9     Document Type: Article
Times cited : (17)

References (27)
  • 1
    • 36148981831 scopus 로고    scopus 로고
    • Rating scales as outcome measures for clinical trials in neurology: Problems, solutions, and recommendations
    • DOI 10.1016/S1474-4422(07)70290-9, PII S1474442207702909
    • Hobart, J.C., S.J. Cano, J.P. Zajicek, and A.J. Thompson. 2007. Rating scales as outcome measures in clinical trials in neurology: Problems, solutions and recommendations. Lancet Neurology 6: 1094-1105. (Pubitemid 350116704)
    • (2007) Lancet Neurology , vol.6 , Issue.12 , pp. 1094-1105
    • Hobart, J.C.1    Cano, S.J.2    Zajicek, J.P.3    Thompson, A.J.4
  • 2
    • 0030267672 scopus 로고    scopus 로고
    • Calibration of measures for psychotherapy outcome studies
    • Sechrest, L., P. McKnight, and K. McKnight. 1996. Calibration of measures for psychotherapy outcomes studies. American Psychologist 51: 1065-1071. (Pubitemid 126418003)
    • (1996) American Psychologist , vol.51 , Issue.10 , pp. 1065-1071
    • Sechrest, L.1    McKnight, P.2    McKnight, K.3
  • 3
    • 0034268999 scopus 로고    scopus 로고
    • Making sense of quality-of-life data
    • Guyatt, G.H. 2000. Making sense of quality-of-life data. Medical Care 38(9 Suppl): II-175-II-179.
    • (2000) Medical Care , vol.38 , Issue.9 SUPPL.
    • Guyatt, G.H.1
  • 4
    • 0037980149 scopus 로고    scopus 로고
    • Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation
    • Norman, G.R., J.A. Sloan, and K.W. Wyrwich. 2003. Interpretation of changes in health-related quality of life: The remarkable universality of half a standard deviation. Medical Care 41: 582-592.
    • (2003) Medical Care , vol.41 , pp. 582-592
    • Norman, G.R.1    Sloan, J.A.2    Wyrwich, K.W.3
  • 5
    • 0024852022 scopus 로고
    • Measurement of health status. Ascertaining the minimal clinically important difference
    • DOI 10.1016/0197-2456(89)90005-6
    • Jaeschke, R., J. Singer, and G.H. Guyatt. 1989. Measurement of health status: Ascertaining the minimal clinically important difference. Control Clinical Trials 10: 407-415. (Pubitemid 20025670)
    • (1989) Controlled Clinical Trials , vol.10 , Issue.4 , pp. 407-415
    • Jaeschke, R.1    Singer, J.2    Guyatt, G.H.3
  • 7
    • 0034266062 scopus 로고    scopus 로고
    • Interpretation of quality of life outcomes, issues that affect magnitude and meaning
    • Testa, M.A. 2000. Interpretation of quality of life outcomes, issues that affect magnitude and meaning. Medical Care 38(9 Suppl): II-166-II-174.
    • (2000) Medical Care , vol.38 , Issue.9 SUPPL.
    • Testa, M.A.1
  • 8
    • 33750460229 scopus 로고    scopus 로고
    • How a well-grounded minimal important difference can enhance transparency of labeling claims and improve interpretation of a patient reported outcome measure
    • Brozek, J.L., G.H. Guyatt, and H.J. Schunemann. 2006. How a well-grounded minimal important difference can enhance transparency of labeling claims and improve interpretation of a patient reported outcome measure. Health and Quality of Life Outcomes 4: 69.
    • (2006) Health and Quality of Life Outcomes , vol.4 , pp. 69
    • Brozek, J.L.1    Guyatt, G.H.2    Schunemann, H.J.3
  • 9
    • 37849014808 scopus 로고
    • Relation of implicit theories to the construction of personal histories
    • Ross, M. 1989. Relation of implicit theories to the construction of personal histories. Psychological Review 96: 341-357.
    • (1989) Psychological Review , vol.96 , pp. 341-357
    • Ross, M.1
  • 11
    • 0033022984 scopus 로고    scopus 로고
    • Methodological approaches for assessing response shift in longitudinal health-related quality-of-life research
    • DOI 10.1016/S0277-9536(99)00047-7, PII S0277953699000477
    • Schwartz, C.E., and M.A.G. Sprangers. 1999. Methodological approaches for assessing response shift in longitudinal health-related quality of life research. Science and Social Medicine 48: 1531-1548. (Pubitemid 29254112)
    • (1999) Social Science and Medicine , vol.48 , Issue.11 , pp. 1531-1548
    • Schwartz, C.E.1    Sprangers, M.A.G.2
  • 12
    • 84858785163 scopus 로고    scopus 로고
    • Opening the black box of cancer patients' quality-of-life change assessments: A qualitative study examining the cognitive processes underlying responses to transition items
    • Forthcoming
    • Taminiau-Bloem, E.F., F.J. van Zuuren, M.R.M. Visser, et al. Forthcoming. Opening the black box of cancer patients' quality-of-life change assessments: A qualitative study examining the cognitive processes underlying responses to transition items. Psychology and Health.
    • Psychology and Health
    • Taminiau-Bloem, E.F.1    Van Zuuren, F.J.2    Visser, M.R.M.3
  • 13
    • 41149086602 scopus 로고    scopus 로고
    • Thurstone scaling as a measurement method to quantify subjective health outcomes
    • Krabbe, P.F.M. 2008. Thurstone scaling as a measurement method to quantify subjective health outcomes. Medical Care 46: 357-365.
    • (2008) Medical Care , vol.46 , pp. 357-365
    • Krabbe, P.F.M.1
  • 16
    • 0242383541 scopus 로고    scopus 로고
    • Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutics misconception
    • DOI 10.1023/A:1026072409595
    • Weinfurt, K.P., D.P. Sulmasy, K.A. Schulman, and N.J. Meropol. 2003. Patient expectations of benefit from phase I clinical trials: Linguistic considerations in diagnosing a therapeutic misconception. Theoretical Medicine 24: 329-344. (Pubitemid 37336581)
    • (2003) Theoretical Medicine and Bioethics , vol.24 , Issue.4 , pp. 329-344
    • Weinfurt, K.P.1    Sulmasy, D.P.2    Schulman, K.A.3    Meropol, N.J.4
  • 17
    • 0004225610 scopus 로고    scopus 로고
    • 2nd ed. (trans: Weinsheimer J., and D.G. Marshall). New York: Continuum Press
    • Gadamer, H. 2003. Truth and Method, 2nd ed. (trans: Weinsheimer J., and D.G. Marshall). New York: Continuum Press.
    • (2003) Truth and Method
    • Gadamer, H.1
  • 18
    • 36049003596 scopus 로고    scopus 로고
    • Denouement: A patient reported observation
    • Chauhan, C. 2007. Denouement: A patient reported observation. Value in Health 10(Suppl. 2): S146-S147.
    • (2007) Value in Health , vol.10 , Issue.SUPPL. 2
    • Chauhan, C.1
  • 19
    • 37549004786 scopus 로고    scopus 로고
    • Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes
    • Revicki, D., R.D. Hays, D. Cella, and J. Sloan. 2008. Recommended methods for determining responsiveness and minimally important differences for patient-reported outcomes. Journal of Clinical Epidemiology 61: 102-109.
    • (2008) Journal of Clinical Epidemiology , vol.61 , pp. 102-109
    • Revicki, D.1    Hays, R.D.2    Cella, D.3    Sloan, J.4
  • 20
    • 16344394276 scopus 로고    scopus 로고
    • Commentary - Goodbye M(C)ID! hello MID, where do you come from?
    • DOI 10.1111/j.1475-6773.2005.0k375.x
    • Schunemann, H.J., and G.H. Guyatt. 2005. Commentary - goodbye M(C)ID! Hello MID, where do you come from? Health Services Research 40: 593-597. (Pubitemid 40470710)
    • (2005) Health Services Research , vol.40 , Issue.2 , pp. 593-597
    • Schunemann, H.J.1    Guyatt, G.H.2
  • 21
    • 77955711063 scopus 로고    scopus 로고
    • Guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims
    • FDA
    • FDA. 2009. Guidance for industry on patient-reported outcome measures: Use in medicinal product development to support labeling claims. Federal Register 74: 1-43.
    • (2009) Federal Register , vol.74 , pp. 1-43
  • 22
    • 0029339531 scopus 로고
    • Weighting health states and strong evaluation
    • Edgar, A. 1995. Weighting health states and strong evaluation. Bioethics 9: 240-251.
    • (1995) Bioethics , vol.9 , pp. 240-251
    • Edgar, A.1
  • 23
    • 0003260361 scopus 로고
    • What is human agency
    • Cambridge: Cambridge University Press
    • Taylor, C. 1985. What is human agency. In Human agency and language: Philosophical papers, vol. 1, 15-44. Cambridge: Cambridge University Press.
    • (1985) Human Agency and Language: Philosophical Papers , vol.1 , pp. 15-44
    • Taylor, C.1
  • 25
    • 33747095820 scopus 로고    scopus 로고
    • Understanding global transition assessments
    • DOI 10.1007/s11136-006-0050-8
    • Wyrwich, K.W., and V.M. Tardino. 2006. Understanding global transition assessments. Quality of Life Research 15: 995-1004. (Pubitemid 44221453)
    • (2006) Quality of Life Research , vol.15 , Issue.6 , pp. 995-1004
    • Wyrwich, K.W.1    Tardino, V.M.2
  • 27
    • 77953666749 scopus 로고    scopus 로고
    • A theoretical framework for patient-reported outcome measures
    • McClimans, L. 2010. A theoretical framework for patient-reported outcome measures. Theoretical Medicine and Bioethics 31: 225-240.
    • (2010) Theoretical Medicine and Bioethics , vol.31 , pp. 225-240
    • McClimans, L.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.